• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NK 细胞在癌症免疫治疗中的作用的新见解。

New insights into the role of NK cells in cancer immunotherapy.

机构信息

Cancer Immunology and Immunotherapy Center; Saint Savas Cancer Hospital; Athens, Greece.

出版信息

Oncoimmunology. 2012 Mar 1;1(2):205-207. doi: 10.4161/onci.1.2.18398.

DOI:10.4161/onci.1.2.18398
PMID:22720243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3376993/
Abstract

Repetitive infusions of ex vivo expanded NK cells induced antitumor T-cell responses in a metastatic lung cancer mouse model. These were further potentiated by Treg depletion. Thus the combination of NK cell-based immunotherapy with other treatment modalities in the direction of adaptive response enhancement might promote long lasting antitumor immunity.

摘要

重复输注体外扩增的自然杀伤(NK)细胞可在转移性肺癌小鼠模型中诱导抗肿瘤 T 细胞反应,而 Treg 细胞耗竭可进一步增强这种反应。因此,基于 NK 细胞的免疫疗法与其他治疗方式相结合,以增强适应性反应,可能会促进长期的抗肿瘤免疫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eae/3376993/12586826763a/onci-1-205-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eae/3376993/12586826763a/onci-1-205-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8eae/3376993/12586826763a/onci-1-205-g1.jpg

相似文献

1
New insights into the role of NK cells in cancer immunotherapy.NK 细胞在癌症免疫治疗中的作用的新见解。
Oncoimmunology. 2012 Mar 1;1(2):205-207. doi: 10.4161/onci.1.2.18398.
2
NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.自然杀伤细胞过继转移联合 Ontak 介导的调节性 T 细胞消除可诱导有效的适应性抗肿瘤免疫应答。
J Immunol. 2011 Mar 15;186(6):3327-35. doi: 10.4049/jimmunol.1000652. Epub 2011 Feb 11.
3
Autologous Immune Enhancement Therapy for Cancer - Our experience since 2004.癌症自体免疫增强疗法——我们自2004年以来的经验
J Stem Cells Regen Med. 2012 Nov 26;8(3):205-6. eCollection 2012.
4
Real-Time Tracking of -Expanded Natural Killer Cells Toward Human Triple-Negative Breast Cancers.实时追踪 - 扩增的自然杀伤细胞对人类三阴性乳腺癌的作用。
Front Immunol. 2018 May 2;9:825. doi: 10.3389/fimmu.2018.00825. eCollection 2018.
5
Hsp70-Activated NK Cells in Combination With PD-1 Inhibition Significantly Increase Overall Survival in Preclinical Models of Glioblastoma and Lung Cancer.热休克蛋白 70 激活的自然杀伤细胞与 PD-1 抑制联合应用显著提高胶质母细胞瘤和肺癌的临床前模型的总生存率。
Front Immunol. 2019 Mar 22;10:454. doi: 10.3389/fimmu.2019.00454. eCollection 2019.
6
CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer.CD4+CD25+ 调节性T细胞抑制自然杀伤细胞介导的癌症免疫治疗。
J Immunol. 2006 Feb 1;176(3):1582-7. doi: 10.4049/jimmunol.176.3.1582.
7
NK cells and ILCs in tumor immunotherapy.自然杀伤细胞和 ILC 在肿瘤免疫治疗中的作用。
Mol Aspects Med. 2021 Aug;80:100870. doi: 10.1016/j.mam.2020.100870. Epub 2020 Aug 13.
8
Expanded Adaptive NK Cells Effectively Kill Primary Acute Lymphoblastic Leukemia Cells.扩展适应性自然杀伤细胞可有效杀伤急性淋巴细胞白血病原始细胞。
Cancer Immunol Res. 2017 Aug;5(8):654-665. doi: 10.1158/2326-6066.CIR-16-0296. Epub 2017 Jun 21.
9
The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation.IL-15 和 IL-21 的协同作用可从 CD3/CD19 depleted 移植物中生成 NK 细胞,从而增强其扩增和对神经母细胞瘤的细胞毒性潜力:对单倍体造血干细胞移植后优化免疫治疗的展望。
Front Immunol. 2019 Dec 3;10:2816. doi: 10.3389/fimmu.2019.02816. eCollection 2019.
10
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.异体培养扩增的 NK 和 NK 样 T 细胞输注治疗癌症患者的安全性分析:一项 I 期临床研究。
Immunotherapy. 2009 Sep;1(5):753-64. doi: 10.2217/imt.09.47.

引用本文的文献

1
The Impact of Different Anesthetics on the Distribution and Cytotoxic Function of NK Cell Subpopulations: An In Vitro Study.不同麻醉剂对 NK 细胞亚群分布和细胞毒性功能的影响:一项体外研究。
Int J Mol Sci. 2024 Oct 14;25(20):11045. doi: 10.3390/ijms252011045.
2
Suppression of the growth and metastasis of mouse melanoma by and tapeworms.抑制小鼠黑色素瘤的生长和转移。
Front Immunol. 2024 Mar 20;15:1376907. doi: 10.3389/fimmu.2024.1376907. eCollection 2024.
3
How tapeworms interact with cancers: a mini-review.绦虫如何与癌症相互作用:小型综述。

本文引用的文献

1
Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression.自体自然杀伤细胞过继转移导致循环自然杀伤细胞水平升高,但不能介导肿瘤消退。
Clin Cancer Res. 2011 Oct 1;17(19):6287-97. doi: 10.1158/1078-0432.CCR-11-1347. Epub 2011 Aug 15.
2
Effect of the simultaneous administration of glucocorticoids and IL-15 on human NK cell phenotype, proliferation and function.糖皮质激素和白细胞介素-15 同时给药对人自然杀伤细胞表型、增殖和功能的影响。
Cancer Immunol Immunother. 2011 Dec;60(12):1683-95. doi: 10.1007/s00262-011-1067-6. Epub 2011 Jun 26.
3
PeerJ. 2024 Mar 29;12:e17196. doi: 10.7717/peerj.17196. eCollection 2024.
4
High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.体外扩增的外周血异体人自然杀伤细胞对膀胱癌的高选择性细胞毒性:经尿道膀胱肿瘤切除术(TURBT)后自然杀伤细胞灌注的意义。
J Exp Clin Cancer Res. 2024 Jan 20;43(1):24. doi: 10.1186/s13046-024-02955-7.
5
Immunotherapy and biomarkers in patients with lung cancer with tuberculosis: Recent advances and future Directions.肺癌合并肺结核患者的免疫治疗与生物标志物:最新进展与未来方向
iScience. 2023 Sep 12;26(10):107881. doi: 10.1016/j.isci.2023.107881. eCollection 2023 Oct 20.
6
Management of Endocrine and Metabolic Toxicities of Immune-Checkpoint Inhibitors: From Clinical Studies to a Real-Life Scenario.免疫检查点抑制剂内分泌和代谢毒性的管理:从临床研究到实际应用场景
Cancers (Basel). 2022 Dec 30;15(1):246. doi: 10.3390/cancers15010246.
7
Advances in the Lung Cancer Immunotherapy Approaches.肺癌免疫治疗方法的进展
Vaccines (Basel). 2022 Nov 19;10(11):1963. doi: 10.3390/vaccines10111963.
8
Cell Therapy With TILs: Training and Taming T Cells to Fight Cancer.肿瘤浸润淋巴细胞(TILs)细胞疗法:训练和驯化 T 细胞以对抗癌症。
Front Immunol. 2021 Jun 1;12:690499. doi: 10.3389/fimmu.2021.690499. eCollection 2021.
9
TNFR2: Role in Cancer Immunology and Immunotherapy.肿瘤坏死因子受体2(TNFR2):在癌症免疫学和免疫治疗中的作用
Immunotargets Ther. 2021 Apr 21;10:103-122. doi: 10.2147/ITT.S255224. eCollection 2021.
10
Biology of NSCLC: Interplay between Cancer Cells, Radiation and Tumor Immune Microenvironment.非小细胞肺癌的生物学:癌细胞、辐射与肿瘤免疫微环境之间的相互作用
Cancers (Basel). 2021 Feb 12;13(4):775. doi: 10.3390/cancers13040775.
NK cell adoptive transfer combined with Ontak-mediated regulatory T cell elimination induces effective adaptive antitumor immune responses.
自然杀伤细胞过继转移联合 Ontak 介导的调节性 T 细胞消除可诱导有效的适应性抗肿瘤免疫应答。
J Immunol. 2011 Mar 15;186(6):3327-35. doi: 10.4049/jimmunol.1000652. Epub 2011 Feb 11.
4
Innate or adaptive immunity? The example of natural killer cells.先天免疫还是适应性免疫?以自然杀伤细胞为例。
Science. 2011 Jan 7;331(6013):44-9. doi: 10.1126/science.1198687.
5
Natural killer cell-based immunotherapy in cancer: current insights and future prospects.基于自然杀伤细胞的癌症免疫疗法:当前见解与未来展望。
J Intern Med. 2009 Aug;266(2):154-81. doi: 10.1111/j.1365-2796.2009.02121.x.
6
Natural killer cell-directed therapies: moving from unexpected results to successful strategies.自然杀伤细胞导向疗法:从意外结果走向成功策略。
Nat Immunol. 2008 May;9(5):486-94. doi: 10.1038/ni1580.
7
A potential role for hydrocortisone in the positive regulation of IL-15-activated NK-cell proliferation and survival.氢化可的松在白细胞介素-15激活的自然杀伤细胞增殖和存活的正向调节中可能发挥的作用。
Blood. 2005 Jul 1;106(1):158-66. doi: 10.1182/blood-2004-08-3232. Epub 2005 Mar 8.
8
NK cell regulation of T cell-mediated responses.自然杀伤细胞对T细胞介导反应的调节。
Mol Immunol. 2005 Feb;42(4):451-4. doi: 10.1016/j.molimm.2004.07.025.
9
Novel APC-like properties of human NK cells directly regulate T cell activation.人类自然杀伤细胞的新型 APC 样特性直接调节 T 细胞活化。
J Clin Invest. 2004 Dec;114(11):1612-23. doi: 10.1172/JCI22787.
10
NK cells and the tumour microenvironment: implications for NK-cell function and anti-tumour activity.自然杀伤细胞与肿瘤微环境:对自然杀伤细胞功能及抗肿瘤活性的影响
Trends Immunol. 2003 Nov;24(11):603-9. doi: 10.1016/j.it.2003.09.007.